Tafero EM Tablets combine Emtricitabine (200 mg) and Tenofovir Alafenamide (25 mg), two potent nucleoside reverse transcriptase inhibitors (NRTIs) used for the treatment and prevention of HIV-1 infection. This formulation is known for its improved safety profile, particularly in terms of kidney and bone health, compared to earlier tenofovir-based treatments. Tafero EM is taken once daily and is suitable for use as part of combination antiretroviral therapy or for pre-exposure prophylaxis (PrEP) in high-risk individuals.

• Dual-action antiretroviral therapy for HIV-1 management and prevention

• Contains Tenofovir Alafenamide, offering lower renal and bone toxicity

• WHO-recommended components for HIV care

• Effective for daily PrEP in individuals at risk of HIV infection

• Convenient once-daily dosing supports long-term adherence

Take one tablet orally, once daily, with or without food. Adherence to daily dosing is crucial for both treatment and PrEP efficacy. Use under medical supervision with regular monitoring and HIV testing.

• Composition: Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg

• Route: Oral

• Usage: As part of HIV-1 combination therapy or for PrEP in high-risk individuals

• Use only under supervision of a qualified healthcare professional

• Not for monotherapy in HIV treatment

• Assess renal function before and during therapy

• Inform your doctor about any existing liver or bone conditions

• Not recommended for individuals with known hypersensitivity to either component

Possible side effects include:

• Headache

• Nausea

• Fatigue

• Diarrhea

• Upper respiratory tract infections

Rare but serious effects may involve lactic acidosis or liver toxicity. Seek immediate medical advice for severe reactions.

• Store at room temperature (15°C–30°C) in a dry, cool place

• Protect from direct sunlight and moisture

• Keep out of reach of children and pets

Q1: What is Tafero EM used for?
Tafero EM is used for treating HIV-1 in combination therapy and for preventing HIV infection (PrEP) in uninfected individuals.

Q2: How is Tenofovir Alafenamide different from Tenofovir DF?
Tenofovir Alafenamide (TAF) offers similar antiviral efficacy with reduced impact on kidneys and bones, making it a safer long-term option.

Q3: Can I take Tafero EM without food?
Yes, it can be taken with or without food. Daily consistency is more important.

Q4: Is Tafero EM effective as PrEP?
Yes. When used daily, it is highly effective in reducing the risk of acquiring HIV.

Q5: Does Tafero EM cure HIV?
No. It helps manage HIV-1 infection but is not a cure. Continued use and monitoring are required.